Abdominal obesity and cardiometabolic risk;Obesidad intraabdominal y riesgo cardiometabólico

Atencion Primaria

Volumn 40, Issue 4, 2008, Pages 199-204

  Franch Nadal, Josep ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; INSULIN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LEPTIN; LIPOPROTEIN; PADGEM PROTEIN; STEROID RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMINAL OBESITY; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETOGENESIS; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEART DISEASE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; METABOLIC DISORDER; OBESITY; PREVALENCE; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 42149152703     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1157/13118063     Document Type: Article

References (46)

1. Pereira JL, Garcia-Luna PP. Costes económicos de la obesidad. Rev Esp Obes. 2005;3:11-2.
2. Encuestas Nacionales de Salud 1993-2003 (datos de obesidad en población mayor de 16 años). Madrid: Ministerio de Sanidad y Consumo; 2006.
3. International Association for the Study of Obesity. Disponible en: http://www.iotf.org/childhoodobesity.asp
4. Plan Integral de la Cardiopatia isquémica 2004-2007. Ministerio de Sanidad y Consumo. Disponible en: http://www.anisalud.com/ficheros/PNCI.pdf
5. Aranceta J, Pérez C, Serra L y grupo colaborativo español para el Estudio de la Obesidad en España. Prevalencia de la obesidad en España: resultados del estudio SEEDO, 2000. Med Clin (Barc). 2003;120:608-12.
6. Guo Z, Hensrud DD, Johnson CM. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes. 1999;48:1586-92.
7. Recasens M, Ricart W, Fernández-Real JM. Obesidad e inflamación. Rev Med Univ Navarra. 2004;48:49-54.
8. Bjorntorp P. Metabolic difference between visceral fat and subcutaneous abdominal fat. Diabetes Metab. 2000;26 Suppl 3:10-2.
9. Poirier P, Despres JP. Obesité et maladies cardiovasculaires. Med Sci (Paris). 2003;19:943-9.
10. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697-738.
11. Bjorntorp P, Visceral obesity: a «civilization syndrome». Obes Res. 1993;1:206-22.
12. Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med. 2006;38:52-63.
13. Beckley ET. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News. 2006;3:1-3.
14. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation. 2006;113:2943-6.
15. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881-7.
16. Despres JP. Health consequences of visceral obesity. Ann Med. 2001;33:534-41.
17. Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K. Central obesity and coronary heart disease in men. Lancet. 1987;1:821-4.
18. Freedman DS, Shear CL, Burke GL, Srinivasan SR, Webber LS, Harsha DW, et al. Persistence of juvenile-onset obesity over eight years: the Bogalusa Heart Study. Am J Public Health. 1987;77:588-92.
19. Karter AJ, D'Agostino RB Jr, Mayer-Davis EJ, Wagenknecht LE, Hanley AJ, Hamman RF, et al. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes Metab. 2005;7:230-8.
20. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol. 1997;145:614-9.
21. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Eqqer F, Bonnadona RC, et al. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord. 2003;27:1283-9.
22. Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism. 2001;50:1499-504.
23. Kvist H, Chowdhury B, Grandgard U, Tyltn U, Sjostrom L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr. 1988;48:1351-61.
24. Bigaard J, Tjonneland A, Thomsen BL, Sorensen TIA. Waist circumference, BMI, smoking and mortality in middle-aged men and women. Obes Res. 2003;11:895-903.
25. Janssen I. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379-84.
26. Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin-resistance: retrospective study. BMJ. 2005;330:1363-4.
27. Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J, et al. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond). 2006;30:475-83.
28. Wannamethee SG, Shaper AG, Morris RW, Whincup PH. Measures of adiposity in the identification of metabolic abnormalities in elderly men. Am J Clin Nutr. 2005;81:1313-21.
29. Mosca L, Edelman D, Mochari H, Christian AH, Paultre F, Pollin I. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day. J Womens Health (Larchmt). 2006;15:24-34.
30. Santi MJ, Carrozas MA, Barba A, Astola A, Jimenez A, Mangas A. Circunferencia de la cintura como predictor de resistencia insulínica en varones jóvenes. Med Clin (Barc). 2005;125:46-50.
31. National Institutes of Health. Clinical Guidelines for the identification, evaluation and treatment of overweight and obesity in adults. NIH Publications. 1998(98):4083.
32. Alberti KGMM, Zimmet P, Shaw J; for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-62. Disponible en: http://www.idf.org/webdata/docs/ IDF_Metasyndrome_definition.pdf
33. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C. Waist circumference and cardiometabolic risk. Diabetes Care. 2007;30:1647-52.
34. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes on abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-8.
35. Hsieh SD, Yoshinaga H. Waist/height ratio as a simple and useful predictor of coronary heart disease risk factors in women. Intern Med. 1995;34:1147-52.
36. Hadaegh F, Zabetian A, Harati H, Azizi F. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men-a 3.6-year prospective study. Exp Clin Endocrinol Diabetes. 2006;114:310-5.
37. Harris MM, Stevens J, Thomas N, Schreiner P, Folsom AR. Associations of fat distribution and obesity with hypertension in a bi-ethnic population: the ARIC study. Atherosclerosis Risk in Communities Study. Obes Res. 2000;8:516-24.
38. Misra A, Madhavan M, Vikram NK, Pandey RM, Dhingra V, Luthra K. Simple anthropometric measures identify fasting hyperinsulinemia and clustering of cardiovascular risk factors in Asian Indian adolescents. Metabolism. 2006;55:1569-73.
39. Sjöstrom L. A computer tomography based multicompartment body composition technique and anthropometric preditcions of lean body mass, total and subcutaneous adipose tissue. Int J Obes. 1991;15:19-30.
40. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men? Circulation. 2000;102:179-84.
41. Martínez Candela J, Franch J, Romero J, Cánovas C, Gallardo A, Paez M. Prevalencia del síndrome metabólico en la población adulta de Yecla (Murcia). Grado de acuerdo entre tres definiciones. Aten Primaria. 2006;38:72-9.
42. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U.S. adults. Obes Res. 2003;11:1223-31.
43. Álvarez-León EE, Ribas Barba L, Serra Majem L. Prevalencia del síndrome metabólico en la población de las Islas Canarias. Med Clin (Barc). 2003;120:172-4.
44. Haffner S, Després JP, Balkau B, Deanfield JE, Barter P, Bassand JP, et al. Waist circumference and Body Mass Index are both independently associated with cardiovascular disease. The International Day for the Evaluation of Abdominal Obesity (IDEA) Survey. ACC Congress; March 2006.
45. Grupo Converge. Identificación, diagnóstico y control del paciente con obesidad abdominal y factores de riesgo cardiovascular y metabólico. Med Clin (Barc). 2007;128:429-37.
46. Van Gaal L, Peiffer F. New approaches of the management of patients with multiple cardiometabolic risk factors. J Endocrinol Invest. 2006;29 Suppl 3:83-9.